Optiver Holding
SLNO

Optiver Holding’s Soleno Therapeutics SLNO Stock Holding History

Optiver Holding’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-284
Closed -$9.51K – 3059
2026
Q1 		$9.51K Buy
284
+74
+35% +$2.9K ﹤0.01% 1222
2025
Q4 		$9.72K Sell
210
-78
-27% -$4.28K ﹤0.01% 1152
2025
Q3 		$19.5K Buy
+288
New +$21.4K ﹤0.01% 979

Optiver Holding's SLNO Position: Q2 2026 in Review

Optiver Holding sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 284 shares — an estimated $9.51K sold.

Optiver Holding first reported a position in SLNO in Q3 2025 and held it in 3 quarters. The position peaked at $19.5K in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

  • Optiver Holding reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 284 Soleno Therapeutics shares in Q2 2026, an estimated $9.51K.
  • Optiver Holding first reported a position in Soleno Therapeutics in Q3 2025 and held it in 3 quarters.
  • Optiver Holding's Soleno Therapeutics position peaked at $19.5K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.